The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC.
 
Mahmut Emre Yildirim
No Relationships to Disclose
 
Mustafa Karaca
No Relationships to Disclose
 
Mehmet Artac
Honoraria - Amgen; Bayer; Merck; Pfizer
Consulting or Advisory Role - Janssen; Novartis/Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Irfan Cicin
Consulting or Advisory Role - Abbvie (Inst); Abdi Ibrahim (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Nobelpharma (Inst); Novartis/Ipsen (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst); Teva
Speakers' Bureau - Abdi Ibrahim (Inst); Astellas Pharma; Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Caglayan Geredeli
No Relationships to Disclose
 
Ahmet Alacacioglu
No Relationships to Disclose
 
Eda Tanrikulu Simsek
No Relationships to Disclose
 
Ahmet Bilici
No Relationships to Disclose
 
Hakan Harputluoglu
No Relationships to Disclose
 
Melike Ozcelik
No Relationships to Disclose
 
Oktay Bozkurt
No Relationships to Disclose
 
Sinemis Yuksel
No Relationships to Disclose
 
Deniz Tural
No Relationships to Disclose
 
Abdullah Sakin
No Relationships to Disclose
 
Timucin Cil
No Relationships to Disclose
 
Basak Bala Oven
No Relationships to Disclose
 
Faysal Dane
No Relationships to Disclose
 
Duygu Cevik
Employment - Amgen
 
Mahmut Gumus
Honoraria - MSD Oncology (Inst)
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Abdurrahman Isikdogan
No Relationships to Disclose